Biotech pubblico
[search 0]
Altro

Scarica l'app!

show episodes
 
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
  continue reading
 
Increase your IQ and understanding of the Biotech industry by listening to interviews with key business leaders who have built successful companies and departments. We discuss everything from the science, clinical operations, clinical development, safety/PV and more! We address how each function plays an important role in the drug approval process. We also discuss the people that make up these departments. Get ready to hear about cutting edge development and the people who make it happen!
  continue reading
 
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
  continue reading
 
T
The Biotech Futurist

1
The Biotech Futurist

thebiotechfuturistpodcast

Unsubscribe
Unsubscribe
Ogni settimana
 
The Biotech Futurist aims to foster deep understanding and discussion about exciting hot topics in biotech at the intersection with artificial intelligence and medicine, exploring CRISPR therapeutics, neuroscience, genetic diseases, interventional genomics, machine learning in biology, behavior, neuroscience, omics, cellular recording, liquid biopsy, oncology, longevity, and more. Your host Luca Fusar Bassini, PhD student at EPFL in Switzerland, interviews an expert guest every week.
  continue reading
 
Grow Everything brings to life the bioeconomy when hosts Karl Schmieder and Erum Azeez Khan share stories from the field and interview leaders and influencers in the space. Life is a powerful force and it can be engineered. What will we create? Learn more at www.messaginglab.com/groweverything Topics: synthetic biology, entrepreneurship, policy, community, education, biotech, life sciences
  continue reading
 
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
  continue reading
 
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday.The host is Jim Cornall.
  continue reading
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
  continue reading
 
Welcome to The Biotech Startups Podcast by Excedr. Join us as we speak with first-time founders, experienced scientists, long-time company operators, serial entrepreneurs, and biotech investors about the challenges and triumphs of running a biotech startup. Gain actionable insight into navigating the ever-changing life sciences industry in each episode as we explore the business of science, from pre-seed to IPO. With your host, Jon Chee.
  continue reading
 
San Diego has grown into one of the largest biotechnology hubs in the United States with some very talented people doing very exciting things. Come along with me as I explore the world of biotech, meet some interesting people, and maybe even learn a thing or two. Oh wait… did I mention there will be beer?
  continue reading
 
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
  continue reading
 
Horizon 3 is a biotech fund which has been formed to help investors to have a real impact on a range of global health challenges through new bio technologies, aiming to de-risk the investment risks inherent in such a technical area.These podcasts are a series aimed at educating investors on the issues, risks and opportunities involved in investing ion the biotech sector.
  continue reading
 
I
Inside Biotech

1
Inside Biotech

Dr. Yewande Pearse, Kathy Grotsch, Ananta Wadhwa

Unsubscribe
Unsubscribe
Ogni mese
 
Inside Biotech is an exciting new podcast from BCLA, which focuses on the science behind SoCals most innovative new biotech companies. This monthly podcast, hosted by Dr. Yewande Pearse, Media & Marketing Associate at BCLA, is the perfect way for LA’s biotech community to stay informed about current progress and developments, and features conversations with scientists, entrepreneurs, and investors about the cutting edge science that goes on inside their companies. On Inside Biotech, science ...
  continue reading
 
A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).
  continue reading
 
Encode Ideas authors research on publicly traded micro / small cap healthcare (biotech & medtech) companies. The Plainspoken podcast is an extension of our research, where we will interview executives from micro / small cap health care companies, portfolio managers who invest in micro / small cap healthcare, and key opinion leaders who can offer insights into therapeutics areas of interest to investors. The podcast is for entertainment purposes only and should not be considered financial adv ...
  continue reading
 
Interviews with the researchers, founders, and investors of the BioTech industry. An insiders look into what is going on in the world of BioTech, from curing aging to psychedelic therapy, we interview the game changers of the industry. The unsung hero's that are moving the industry forward in a significant way. The world is going to be a vastly different place in the next 10-20 years because of what's happening in the BioTech industry right now.Human civilization will move forward farther, f ...
  continue reading
 
Loading …
show series
 
The 400th episode also represents the first episode of the 9th year-- an amazing run for a tiny, self-produced podcast. Where did it come from? In this episode I talk about the genesis of the Talking Biotech podcast, from the Vern Blazek Science Power Hour, to an arm twisting by Joe Rogan, to being banned from podcasting by my university-- this is …
  continue reading
 
Episode Description:In this episode of Grow Everything, Karl and Erum are joined by Andrew Hessel, co-founder of Humane Genomics, for an engaging discussion on various topics related to genomics and technology. They explore the intriguing concept of reverse genome sequencing and its potential applications. The conversation also delves into the urge…
  continue reading
 
1:24 Labiotech news 3:40 BC Platforms A conversation about precision medicine with Tero Silvola, CEO at BC Platforms. We also discuss the acquisition of 4Pharma. The acquisition expands BCP’s global service offering for accelerating the translation of innovations into clinical practice. In addition, 4Pharma customers will benefit from additional se…
  continue reading
 
Good morning from Pharma and Biotech daily, the podcast that brings you the latest news from the world of Pharma and Biotech. The Federal Trade Commission (FTC) has urged North Carolina legislators to drop a bill that would exempt UNC Health from antitrust laws. The FTC argues that such a move would be detrimental to patients, particularly people o…
  continue reading
 
Synopsis: Detlev Biniszkiewicz is the Founder and CEO of NextPoint Therapeutics, a company advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Detlev discusses the immuno-oncology landscape including its challenges and opportunities, and the work his team is pursuing at NextPoint to deliver new the…
  continue reading
 
How about play in animals? Today I have the pleasure to discuss outstanding research in ethology with Elisabetta Palagi from the University of Pisa, who has been a leader in Primatology for over 30 years, and, among several successes, was recently awarded the Animal Behavior Society Fellowship Award for her outstanding research. In this episode, we…
  continue reading
 
Dr. Paul Peter Tack, CEO of Candel Therapeutics, unveils their groundbreaking approach to cancer treatments using engineered viruses. Discover how these viruses are harnessed to target solid tumors, deliver therapeutic genes, and activate the patient's immune system for a powerful anti-cancer response.…
  continue reading
 
“I won't say that we had this all planned out because when I started, it was just a crazy idea that we were excited about, but it ended up working out really well where we're trying to create a new class of medicine with digital therapeutics or with prescription digital therapeutics.” Scott Xiao, Co-Founder and CEO, Luminopia. What’s possible when …
  continue reading
 
Allan Shaw isn't the only insider who's preemptively critical of the impact the IRA (Inflation Reduction Act) will have on the biopharma industry. Allan's back this week with analysis of what he and others are tongue-in-cheek calling the "innovation reduction act." He posits that the act's removal of certain protections will stifle momentum by disi…
  continue reading
 
Part 1 of 3. My guest for this week’s episode is Steve Visco. Steve is the Co-founder, CTO, and CEO of PolyPlus. Before PolyPlus, Steve worked at Lawrence Berkeley National Lab as a Principal Investigator, running several programs in the field of solid state ionics, developing an extensive patent portfolio, much of which has been licensed to indust…
  continue reading
 
On this episode of BioTech IQ, Ammon interviews Paul Lammers the CEO of Triumvira about developing autologus cell therapies using their T-Cell Antigen Coupler Platform (TAC). During this insightful discussion Paul talks about how he started in the industry, running a biotech company in today's environment, and what sets Triumvira's T-Cell therapy a…
  continue reading
 
17th Edition Project Portfolio and Resource Management Excellence for Pharma July 11-13, 2023 | Sheraton Philadelphia University City Hotel | Philadelphia, PA Mastering Resource and Project Prioritization, Operational Excellence, and People Development…The post 17th Edition Project Portfolio and Resource Management Excellence for Pharma appeared fi…
  continue reading
 
DrugChatter recently launched as an experimental AI chat-based business intelligence tool. Here’s some of the more interesting questions it’s been asked: Cost savings for bulk lipitor Who Invented Advil? What…The post DrugChatter Featured Questions appeared first on DrugPatentWatch - Make Better Decisions.…
  continue reading
 
Good morning from Pharma and Biotech daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world. Establishing a relationship with a partner who has the right equipment, scientific expertise, and project management skills is crucial to mitigating risk in tech transfer and controlling costs. A recent webinar hoste…
  continue reading
 
Synopsis: Eric Dobmeier is the President and CEO of Chinook Therapeutics, a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases. Eric discusses how his early years as a lawyer working in-house as general counsel for Seattle Genetics (now Seagen), ultimatel…
  continue reading
 
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in Pharma and Biotech world. Novo Nordisk is reportedly in talks to acquire French medical device-maker Biocorp for $165m, with a focus on drug delivery solutions for chronic diseases like diabetes. Meanwhile, Grail, a liquid biopsy maker, has blame…
  continue reading
 
Synopsis: Faraz Ali is the CEO of Tenaya Therapeutics, a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease. Faraz discusses his non-traditional background as an electrical engineer before he found his passion for applying science an…
  continue reading
 
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world. Today, UnitedHealth has withdrawn its controversial gastroenterology prior authorization plan which required doctors to get approval before prescribing certain medications for digestive diseases like Crohn's and ulce…
  continue reading
 
Vaccination is a cornerstone of animal health, and is critically important in animal agricultural operations. A number of devastating livestock diseases are prevented with vaccination, yet vaccines have not been developed for some of the most devastating diseases for several reasons. Long before the COVID pandemic and its slate of next-gen vaccine …
  continue reading
 
Episode Description: In this episode of Grow Everything, Karl and Erum are joined by Nili Ostrov, co-founder of Cultivarium, as they explore the fascinating world of biotechnology. They discuss the challenges of working with new organisms, the importance of community in biotech, and the need for resources to be available for non-model microbes. The…
  continue reading
 
1:18 Labiotech news 3:37 BioInvent BioInvent International AB, a Swedish biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, and Transgene, a biotech company that designs and develops virus-based immunotherapeutics against cancer, recently announced positive pha…
  continue reading
 
Good morning from Pharma and Biotech Daily, the podcast that brings you the latest news from the world of Pharma and Biotech. Pfizer has announced that Marstacimab, its hemophilia drug, has successfully completed Phase 3 trials. While gene therapies are emerging on the market in the US, this drug could provide another option for hemophilia patients…
  continue reading
 
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world. French drugmaker Sanofi has a promising multiple sclerosis drug in its portfolio, licensed from biotech Immunext in 2017. On the other hand, Biohaven is seeking approval of a treatment that failed a phase 3 trial but…
  continue reading
 
What if we had a ChatGPT for transcriptomics, what if we could predict how the gene network is changed in diseases for which we have scarce molecular data? Today I have the immense pleasure to discuss transformers in single-cell transcriptomics to make huge predictions about gene modulation with Christina Theodoris, who today first-authored a paper…
  continue reading
 
Discover the limitless potential of mRNA engineering as Dr. Francois Vigneault, Co-Founder and CEO of Shape Therapeutics, discusses their groundbreaking work in using mRNA to address genetic mutations in diseases like Parkinson's and Alzheimer's, offering hope for effective treatments and prevention strategies. Join us as we delve into the world of…
  continue reading
 
Synopsis: Gregory Verdine, Ph.D., is the Co-Founder, President and CEO of LifeMine Therapeutics and FogPharma. LifeMine Therapeutics is reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere. FogPharma is developing a new class of drugs to address the limitations of today’s precision medicines and achieve…
  continue reading
 
Good morning from Pharma and Biotech Daily, the podcast that brings you the latest news in the pharma and biotech world.Pfizer has announced that Marstacimab, its hemophilia drug, has successfully completed a Phase 3 study, outperforming factor treatment without safety concerns. However, Amylyx Biotech received bad news as the European Medicines Ag…
  continue reading
 
Synopsis: Kate Haviland is the CEO of Blueprint Medicines, a global precision therapy company that creates life-changing medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, they create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of di…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ## Pfizer and BioNTech COVID-19 Vaccine Granted Emergency Use Authorization in the USThe Pfizer-BioNTech COVID-19 vaccine has been granted emergency use authorization by the US Food and Drug Administration. The vaccine, …
  continue reading
 
The Business of Biotech took a road trip to Pittsburgh to visit with Peptilogics CEO and founder Dr. Jonathan Steckbeck, whose Ph.D. work was inspired by the loss of his father-in-law to a hospital-borne infection. That work subsequently led to the formation of a company committed to leveraging peptide therapeutics to address PJI (prosthetic joint …
  continue reading
 
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in Pharma and Biotech world. Online pharmacy PillPack, which is owned by Amazon, has reported a data breach that affected more than 19,000 customers. The breach exposed customer email addresses, prescription information and contact details for presc…
  continue reading
 
Sam Kean is a prolific author that has a unique talent for sharing the stories of science. Trained in physics, Kean's work describes seminal events in science using a deeply researched narrative style that transforms textbook information into better-than-fiction stories of discovery. In today's episode guest co-host Gracelyn Byrd joins the podcast …
  continue reading
 
Episode Description:In this episode of the Grow Everything podcast, Karl and Erum discuss the exciting advancements in biotech and highlight key moments from previous episodes. They emphasize the importance of sustainable practices and the positive impact biotechnology can have on the environment. They invite listeners to tune in to their podcast a…
  continue reading
 
1:33 Labiotech news 3:31 Daiichi Sankyo/AstraZeneca The companies Daiichi Sankyo and AstraZeneca have worked together for several years. This week’s podcast is sponsored by Daiichi Sankyo and AstraZeneca. On this week’s podcast, we have a conversation with Markus Kosch, the head of Oncology Europe and Canada for Daiichi Sankyo, and Greg Rossi, Seni…
  continue reading
 
Good morning from Pharma and Biotech Daily, the podcast that brings you the latest news from the world of pharma and biotech. The FDA has delayed its decision on Sarepta's Duchenne gene therapy, while PTC is redirecting its resources towards other therapies. Krystal Gene Therapy has been approved for a rare wound disorder, and Novartis is set to bu…
  continue reading
 
Good morning from Pharma and Biotech daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world. The US FDA has delayed its decision on Sarepta's gene therapy for Duchenne muscular dystrophy by a month. Novo Nordisk has announced an oral version of its obesity drug Wegovy will be submitted for regulatory approva…
  continue reading
 
200,000 men at diagnosed each year with Prostate cancer … beginning a journey of many successive treatments. Still, 35,000 men die as a result of prostate cancer. Convergent Therapeutics is focusing on the most advanced, intractable cases of prostate cancer. We speak with, Dr. Philip Kantoff is its Co-Founder, Chief Medical Officer and CEO.…
  continue reading
 
Synopsis: Asit Parikh, M.D., Ph.D., is the President and CEO of MOMA Therapeutics, a biotech company discovering the next generation of precision medicines by targeting highly dynamic proteins that underlie human disease. Asit discusses his experience and learnings being the CEO of a biotech for the first time and his approach to recruiting high qu…
  continue reading
 
Good morning from Pharma and Biotech Daily, the podcast that brings you the latest news from the Pharma and Biotech world. PulseAI has developed an algorithm that outperforms Apple's pre-installed software in detecting atrial arrhythmias. Orthopedic markets are predicted to return to normal growth this year, despite a slowdown expected for the knee…
  continue reading
 
Good morning from Pharma Daily, the podcast that gives you only what's important to hear in Pharma and Biotech world. In today's news, Beta Bionics has gained FDA approval for its automated insulin pump, while Vicarious aims to compete with Intuitive in robotic surgery. Thermo Fisher has also received FDA clearance for a blood test that predicts se…
  continue reading
 
Introducing DrugChatter.com: Empowering Access to Biopharmaceutical Drug Insights through AI Chat We are pleased to introduce DrugChatter.com, a groundbreaking platform that redefines the way professionals obtain concise, cited information on…The post DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights appeared first on DrugPatentWatch - M…
  continue reading
 
Since Dan O'Connor stepped in as CEO at Ambrx late last year, the company's stock has rallied on the revival of a previously-shelved anti-HER2 ADC. It also raised $78 million and completed its ATM (at-the-market) offering. O'Connor is no stranger to overcoming adversity. A former marine captain, he was among the first deployed to the Persian Gulf t…
  continue reading
 
Good morning from Pharma and Biotech Daily, the podcast that brings you the latest news from the world of pharma and biotech. Here are the headlines for today:The US Supreme Court has ruled in favour of Sanofi and Regeneron in a patent dispute with Amgen over their cholesterol-lowering drug Praluent. The court held that Amgen's patent on its rival …
  continue reading
 
The human brain is complex, but over the years massive data have been gathered regarding the relationship between structure and function. From functional MRI to many other techniques, researchers slowly are resolving the relationship between brain anatomy and how it actually works. Dr. Stephan Doyen of Omniscient Neurotechnology have designed tools…
  continue reading
 
Loading …

Guida rapida